Research area
Schizophrenia trials open to children and teens
Schizophrenia studies open to children and teens look at investigational medications and support programs, and some focus on symptoms that current care leaves unaddressed. CNS Pediatric Trials can help you find out whether one of them may be a fit for your child.
Updated
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Schizophrenia studies open to children and teens in numbers
- schizophrenia studies open to children and teens recruiting in the U.S.
- 12
- states with a study site
- 23
- studies that accept healthy volunteers
- 1
Source: ClinicalTrials.gov. Data processed .
Schizophrenia studies open to children and teens recruiting now
As of November 18, 2026, 12 schizophrenia studies open to children and teens are recruiting participants in the United States, according to ClinicalTrials.gov. This site lists only studies that set an upper age limit, with at least half of the ages they accept under 18, as each study is coded in the registry. This is what they have in common.
What they test
- medications7
- behavioral approaches such as talk therapy or training4
- diagnostic tests1
- genetic approaches1
- other approaches1
A study can test more than one.
Main purpose
- treating a condition8
- prevention2
- diagnosis1
- other purposes1
Phase
- Phase 11
- Phase 35
- Phase 41
- No phase5
Studies of devices and behavioral approaches have no phase.
Who runs them
- industry7
- university, hospital or other5
Who they enroll
- adults (18 to 64)4
- mainly children and teens (under 18)12
1 also accept healthy volunteers.
These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.
Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 12 studies.
Recently updated schizophrenia studies open to children and teens
The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
- Phase 3
- Ages 13 to 17
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Recruiting in
- Anaheim, CA · Atlanta, GA · Boston, MA · and 11 more U.S. locations
- Registry record
- NCT07288567 · updated
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Phase 3
- Ages 5 to 17
- All sexes
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Recruiting in
- Anaheim, CA · Atlanta, GA · Boston, MA · and 11 more U.S. locations
- Registry record
- NCT07424404 · updated
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- Phase 3
- Ages 5 to 17
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Recruiting in
- Anaheim, CA · Atlanta, GA · Bellevue, WA · and 36 more U.S. locations
- Registry record
- NCT06229210 · updated
Developing Biomarker-Supported Schizophrenia Spectrum Disorder (SSD) Prevention
- No phase
- Ages 9 to 26
- All sexes
- Sponsor
- The University of Texas Health Science Center, Houston
- Recruiting in
- Houston, TX
- Registry record
- NCT07743645 · updated
Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
- Phase 4
- Ages 12 to 17
- All sexes
- Sponsor
- Vanda Pharmaceuticals
- Recruiting in
- Atlanta, GA · Cincinnati, OH · Decatur, GA · and 7 more U.S. locations
- Registry record
- NCT05648591 · updated
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
- Phase 3
- Ages 10 to 17
- All sexes
- Sponsor
- Alkermes, Inc.
- Recruiting in
- Chicago, IL · Cincinnati, OH · Decatur, GA · and 12 more U.S. locations
- Registry record
- NCT05303064 · updated
Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in the United States on ClinicalTrials.gov.
What schizophrenia studies look at
The schizophrenia studies open to children and teens test medications that are still investigational, and some test support programs. Part of this work looks at symptoms that existing care does not reach. Every study is built around a single question. For that reason, what your child would be asked to do in one study can look quite different from what another involves.
Whatever a study is testing counts as investigational. Researchers do not yet know how well it works or what risks it carries. Finding that out is why the study is being run.
Who may be able to take part
Who can take part is set separately by each study. Requirements may cover your child's age and health history, any medications they currently take, and the way a condition affects them. There are also studies that enroll young people without the condition.
Eligibility is not something you have to figure out on your own. During a screening visit, the study team does that check. Find out how screening and eligibility work.
What taking part usually involves
A first conversation
First comes a conversation. You hear a general outline of the study from a coordinator, who also takes your questions, and nothing further happens until that is done.
Informed consent
Everything about the study is put on paper for you by the study team, with the known risks spelled out. Saying yes or no on your child's behalf is your choice.
Screening
Health questions and tests show whether the study suits your child. Some children and teens who are screened do not go on to take part.
Study visits
If your child joins, they come to scheduled visits so the team can follow their health. Your child can leave the study at any time.
Questions about schizophrenia studies open to children and teens
Does my child need a diagnosis to join a study about schizophrenia?
That varies by study. Certain studies want a diagnosis already confirmed, and others assess your child as part of screening. Which one applies is something the study team will tell you.
Would my child have to change the care they receive now?
It depends on the study. Some let a young person keep their current care, and others do not. The study doctor goes through this with you, and your child's regular doctor can be part of the conversation ahead of any decision. Whatever the study, changing the care your child has now is not something to do on your own.
Is there a cost to take part?
As a rule, there is no cost to your family for the visits, the tests, or the medication that belong to the study. Our page on costs explains more.
Ask about schizophrenia studies open to children and teens
A coordinator will contact you once you send a few details. Asking is just asking. It commits neither you nor your child to anything.
Independent information
- Schizophrenia — National Institute of Mental Health (NIH)
- Clinical Trials – Information for Participants — National Institute of Mental Health (NIH)
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)